Sponsor:
Galderma R&D
Code:
NCT07566286
Conditions
Chin Augmentation
Eligibility Criteria
Sex: All
Age: 22+
Healthy Volunteers: Accepted
Interventions
Restylane Lyft with Lidocaine
Brief summary:
Conditions
Chin Augmentation
Study ID
NCT07566286
Start date
Jun 3, 2026
Status verified date
Aug, 2026
Completion date
Feb 28, 2028
Anticipated
Primary completion date
Nov 1, 2027
Anticipated
Eligibility Criteria
Sex: All
Age: 22+
Healthy Volunteers: Accepted
Enrollment
100 participants
Anticipated
Intervention Model
Single group
Primary purpose
Treatment
Arms
experimental: Dermal Filler for Indication: Restylane Lyft with Lidocaine
Interventions
Restylane Lyft with Lidocaine
Primary outcome measure
Central contacts
Locations
Galderma Investigational Site # 8680
Recruiting
Westport, Connecticut, United States, 06880
Galderma Investigational Site # 8774
Recruiting
Boynton Beach, Florida, United States, 33437
Galderma Investigational Site # 7030
Recruiting
Coral Gables, Florida, United States, 33134
Galderma Investigational Site # 8682
Recruiting
Coral Gables, Florida, United States, 33134
Galderma Investigational Site # 7042
Recruiting
Atlanta, Georgia, United States, 30331
Galderma Investigational Site # 7118
Recruiting
Nashville, Tennessee, United States, 37203
Galderma Investigational Site # 8662
Recruiting
Spring, Texas, United States, 77388
Sponsor
Galderma R&D
Last update posted
Aug 14, 2026
Last verified
Aug, 2026
Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-08. This information was provided to ClinicalTrials.gov by Galderma R&D on 2026-08-14.